These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Proceedings: The comparison of the bioavailabilities of commercial nitrofurantoin tablets. McGilveray IJ, Mattok GL, Hossie RD. Rev Can Biol; 1973 Nov; 32():Suppl:99-106. PubMed ID: 4777608 [No Abstract] [Full Text] [Related]
7. Pharmaceutical availability from oral dosage forms: in vitro release of nitrofurantoin from tablets and capsules. Senjković R, Kallay N, Vilendecić M. Pharmazie; 1987 Mar; 42(3):186-8. PubMed ID: 3602077 [Abstract] [Full Text] [Related]
8. Effect of formulation and process variables on bioequivalency of nitrofurantoin II: in vivo-in vitro correlation. Mendes RW, Masih SZ, Kanumuri RR. J Pharm Sci; 1978 Nov; 67(11):1616-9. PubMed ID: 712603 [Abstract] [Full Text] [Related]
9. In vitro and in vivo evaluation of seven 50 mg and 100 mg nitrofurantoin tablets. Meyer MC, Wood GC, Straughn AB. Biopharm Drug Dispos; 1989 Nov; 10(3):321-9. PubMed ID: 2720135 [Abstract] [Full Text] [Related]
19. Laboratory studies with nitrofurantoin. Relationship between crystal size, urinary excretion in the rat and man, and emesis in dogs. Paul HE, Hayes KJ, Paul MF, Borgmann AR. J Pharm Sci; 1967 Jul; 56(7):882-5. PubMed ID: 6034831 [No Abstract] [Full Text] [Related]
20. Urinary excretion in the rat of nifurpipone (NP) and of nitrofurantoin (NTF) administered by different routes. Veronese M, Salvaterra M, Barzaghi D, Setnikar I. Arzneimittelforschung; 1974 Jan; 24(1):39-43. PubMed ID: 4206385 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]